US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

17.81

-0.4300-2.36%

Volume:1.56M

Turnover:27.67M

Market Cap:1.75B

PE:-6.88

High:18.27

Open:18.02

Low:17.51

Close:18.24

Loading ...

Overview Company News Filings

U.S. FDA Grants Platform Technology Designation to the Viral Vector Used in Srp-9003, Sarepta’s Investigational Gene Therapy for the Treatment of Limb Girdle Muscular Dystrophy Type 2E/R4

THOMSON REUTERS

Gene Therapy Death Worsens Picture for an Already Troubled Field -- Barrons.com

Analysts Offer Insights on Healthcare Companies: NovoCure (NVCR) and Sarepta Therapeutics (SRPT)

Sarepta Therapeutics Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Sarepta jumps 5% to $42.11 after UK allows Elevidys study to continue

Sarepta Therapeutics Stock Gains After U.K. Lets Elevidys Study Continue

Sarepta Therapeutics Says Dosing to Continue in UK Trial of Duchenne Muscular Dystrophy Treatment

MT Newswires Live

BRIEF-Sarepta Provides Update on UK Dosing in ENVISION Study of ELEVIDYS for the treatment of Duchenne Muscular Dystrophy

Sarepta announces MHRA says ENVISION dosing may continue as planned

Sarepta Therapeutics Receives MHRA Approval to Continue Dosing in Phase 3 Study of ELEVIDYS for Duchenne Muscular Dystrophy

Sarepta Therapeutics Inc - Mhra Allows Dosing to Continue in UK Envision Study

THOMSON REUTERS

Sarepta Provides Update on UK Dosing in Envision Study of Elevidys for the Treatment of Duchenne Muscular Dystrophy

THOMSON REUTERS

Sarepta Shares Higher After J.P. Morgan Note

Sarepta Therapeutics Is Maintained at Overweight by JP Morgan

Buy Rating on Sarepta Therapeutics: Valuation Disconnect and Growth Potential Highlighted by Elevidys Approval

Sarepta Therapeutics Inc : JP Morgan Cuts Target Price to $84 From $169

THOMSON REUTERS

Sarepta Reports New Elevidys Data from Two Separate Studies in Duchenne Muscular Dystrophy

MT Newswires Live

Sarepta Therapeutics Shares New Protein Expression and Safety Results From Endeavor in Participants 2 Years Old at Time of Treatment

THOMSON REUTERS

Sarepta Therapeutics Inc: Treatment With Elevidys Demonstrated Mean Expression of 93.87% of Normal, as Measured by Western Blot

THOMSON REUTERS

Sarepta Therapeutics: Hold Rating Amid Limited Financial Gains from ELEVIDYS Approval and Market Adoption Concerns

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SRPT/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SRPT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SRPT\",,,,,undefined,":{"symbol":"SRPT","market":"US","secType":"STK","nameCN":"Sarepta Therapeutics","latestPrice":17.81,"timestamp":1751907136642,"preClose":18.24,"halted":0,"volume":1557572,"delay":0,"floatShares":93857602,"shares":98277032,"eps":-2.589593,"marketStatus":"Trading","change":-0.43,"latestTime":"07-07 12:52:19 EDT","open":18.02,"high":18.27,"low":17.51,"amount":27670585.882260002,"amplitude":0.041667,"askPrice":17.81,"askSize":29,"bidPrice":17.8,"bidSize":238,"shortable":3,"etf":0,"ttmEps":-2.589593,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1751918400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":865396800000,"exchange":"NASDAQ","adjPreClose":18.24,"preHourTrading":{"tag":"盘前","latestPrice":18,"preClose":18.24,"latestTime":"09:29 EDT","volume":11081,"amount":200415.19894200002,"timestamp":1751894942585},"postHourTrading":{"tag":"盘后","latestPrice":18.2101,"preClose":18.24,"latestTime":"16:58 EDT","volume":61039,"amount":1113101.9525,"timestamp":1751576285809},"volumeRatio":0.660528,"impliedVol":1.1406,"impliedVolPercentile":0.988},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SRPT\",,,,,undefined,":{"symbol":"SRPT","floatShares":93857602,"roa":"-2.19%","roe":"-23.61%","lyrEps":2.474246,"volumeRatio":0.660528,"shares":98277032,"dividePrice":0,"high":18.27,"amplitude":0.041667,"preClose":18.24,"low":17.51,"week52Low":16.88,"pbRate":"1.53","psRate":"0.78","week52High":154.9,"institutionHeld":0.9011,"latestPrice":17.81,"committee":0.782772,"eps":-2.589593,"divideRate":0,"volume":1557572,"delay":0,"ttmEps":-2.589593,"open":18.02,"prevYearClose":121.59,"prevWeekClose":18.24,"prevMonthClose":17.1,"prevQuarterClose":17.1,"fiveDayClose":17.11,"twentyDayClose":39.21,"sixtyDayClose":49.3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SRPT\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540069961","title":"U.S. FDA Grants Platform Technology Designation to the Viral Vector Used in Srp-9003, Sarepta’s Investigational Gene Therapy for the Treatment of Limb Girdle Muscular Dystrophy Type 2E/R4","url":"https://stock-news.laohu8.com/highlight/detail?id=2540069961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540069961?lang=en_us&edition=fundamental","pubTime":"2025-06-04 21:30","pubTimestamp":1749043800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nTUA3TXR7R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4139","IE0009355771.USD","IE0002141913.USD","IE00B2B36J28.USD","BK4585","SRPT","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2538049348","title":"Gene Therapy Death Worsens Picture for an Already Troubled Field -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2538049348","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538049348?lang=en_us&edition=fundamental","pubTime":"2025-05-28 00:11","pubTimestamp":1748362260,"startTime":"0","endTime":"0","summary":"The death of a patient in a trial of an experimental gene therapy casts new shadows over a technology once seen as the future of the drug industry.Rocket Pharmaceuticals, a New Jersey-based biotech, said early Tuesday that a patient participating in a small trial of a gene therapy died over the weekend. The therapy is meant to treat a rare genetic condition called Danon Disease, which weakens the heart muscle and generally kills male patients in early adulthood. Rocket shares fell 58.6% on Tuesday.The gene therapy, called RP-A501, was being tested in a Phase 2 trial -- the last step before Rocket planned to submit the treatment for Food and Drug Administration approval. Analysts had been reasonably confident that the trial would be successful: In February, Jefferies analysts Andrew Tsai wrote that he put 65% to 75% odds on a positive readout.Or take Pfizer, which in 2019 unveiled plans to invest hundreds of millions of dollars in a \"state-of-the-art gene therapy manufacturing f","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","BK4588","RCKT","IE0002141913.USD","BK4585","NVS","LU0208291251.USD","BK4556","IE00B2B36J28.USD","LU0070302665.USD","BK4007","IE00BJT1NW94.SGD","LU0211331839.USD","IE0009355771.USD","BLUE","LU0320765489.SGD","IE00B4R5TH58.HKD","SRPT","IE00BFTCPJ56.SGD","BK4532","BK4139","IE00BJJMRZ35.SGD"],"gpt_icon":1},{"id":"2537928944","title":"Analysts Offer Insights on Healthcare Companies: NovoCure (NVCR) and Sarepta Therapeutics (SRPT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2537928944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537928944?lang=en_us&edition=fundamental","pubTime":"2025-05-22 23:10","pubTimestamp":1747926604,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on NovoCure (NVCR – Research Report) and Sarepta Therap...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novocure-nvcr-and-sarepta-therapeutics-srpt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novocure-nvcr-and-sarepta-therapeutics-srpt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4137","IE00B2B36J28.USD","BK4534","IE00BJJMRZ35.SGD","BK4139","SRPT","IE00BJT1NW94.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","NVCR","HCSG","IE0002141913.USD","BK4548","BK4082"],"gpt_icon":0},{"id":"2537949943","title":"Sarepta Therapeutics Price Target Maintained With a $40.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2537949943","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537949943?lang=en_us&edition=fundamental","pubTime":"2025-05-22 19:29","pubTimestamp":1747913340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SRPT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 22, 2025 07:29 ET (11:29 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRPT"],"gpt_icon":0},{"id":"2537934867","title":"Sarepta jumps 5% to $42.11 after UK allows Elevidys study to continue","url":"https://stock-news.laohu8.com/highlight/detail?id=2537934867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537934867?lang=en_us&edition=fundamental","pubTime":"2025-05-21 22:40","pubTimestamp":1747838413,"startTime":"0","endTime":"0","summary":"10:35 EDT Sarepta (SRPT) jumps 5% to $42.11 after UK allows Elevidys study to continue Published first on TheFly – the ultimate source for real-tim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sarepta-jumps-5-to-42-11-after-uk-allows-elevidys-study-to-continue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sarepta-jumps-5-to-42-11-after-uk-allows-elevidys-study-to-continue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4139","IE0002141913.USD","SRPT","BK4585"],"gpt_icon":0},{"id":"2537193181","title":"Sarepta Therapeutics Stock Gains After U.K. Lets Elevidys Study Continue","url":"https://stock-news.laohu8.com/highlight/detail?id=2537193181","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537193181?lang=en_us&edition=fundamental","pubTime":"2025-05-21 22:18","pubTimestamp":1747837080,"startTime":"0","endTime":"0","summary":"Shares of Sarepta Therapeutics advanced after the company said it has received the go-ahead from U.K. regulators to keep dosing in a study of its Elevidys treatment for Duchenne muscular dystrophy.The stock was up 6.3% at $42.52 in early trading. Shares are still down 65% since the start of the year.The gene-therapy developer said Wednesday that it had gotten feedback from Britain's Medicine and Healthcare Products Regulatory Agency that would allow dosing for the study to continue uninterrupted.The Phase 3 study is global, randomized, double-blind and placebo-controlled, and examines the Elevidys treatment in non-ambulatory and older ambulatory individuals with Duchenne muscular dystrophy.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE0009355771.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4585","BK4139","SRPT","IE0002141913.USD"],"gpt_icon":0},{"id":"2537933742","title":"Sarepta Therapeutics Says Dosing to Continue in UK Trial of Duchenne Muscular Dystrophy Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2537933742","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537933742?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:00","pubTimestamp":1747832459,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics  said Wednesday that the UK's Medicines & Healthcare products Regulatory Agency has allowed dosing to continue uninterrupted in the phase 3 study of its Elevidys gene therapy treatment.The study is evaluating the treatment in non-ambulatory and older ambulatory individuals with Duchenne muscular dystrophy, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJJMRZ35.SGD","IE0002141913.USD","SRPT","IE0009355771.USD","BK4139","BK4585","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2537933169","title":"BRIEF-Sarepta Provides Update on UK Dosing in ENVISION Study of ELEVIDYS for the treatment of Duchenne Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2537933169","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537933169?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:55","pubTimestamp":1747832138,"startTime":"0","endTime":"0","summary":"BRIEF-Sarepta Provides Update on UK Dosing in ENVISION Study of ELEVIDYS for the treatment of Duchenne Muscular DystrophyMay 21 (Reuters) - Sarepta Therapeutics Inc SRPT.O:SAREPTA PROVIDES UPDATE ON U","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nTUAX6SGJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE0009355771.USD","IE0002141913.USD","SRPT","BK4585","IE00BFTCPJ56.SGD","BK4139","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2537333949","title":"Sarepta announces MHRA says ENVISION dosing may continue as planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2537333949","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537333949?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:35","pubTimestamp":1747830946,"startTime":"0","endTime":"0","summary":"Sarepta (SRPT) shared the following update related to Elevidys, the only approved gene therapy for patients with Duchenne muscular dystrophy. The c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sarepta-announces-mhra-says-envision-dosing-may-continue-as-planned?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sarepta-announces-mhra-says-envision-dosing-may-continue-as-planned?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","BK4585","IE0009355771.USD","BK4139","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","SRPT","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2537938236","title":"Sarepta Therapeutics Receives MHRA Approval to Continue Dosing in Phase 3 Study of ELEVIDYS for Duchenne Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2537938236","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537938236?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:31","pubTimestamp":1747830679,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics Inc. announced an update regarding its ongoing regulatory review for ELEVIDYS, a gene therapy for Duchenne muscular dystrophy. The Medicines & Healthcare products Regulatory Agency  in the United Kingdom has given the green light for dosing to continue uninterrupted in the ENVISION study, which is a global Phase 3 trial. This study involves both non-ambulatory and older ambulatory individuals with Duchenne and is designed as a randomized, double-blind, placebo-controlled trial. Sarepta, a leader in precision genetic medicine for rare diseases, emphasized the significance of this approval as it continues to advance its treatment for Duchenne muscular dystrophy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sarepta ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL43Vp5v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","IE00B2B36J28.USD","IE00BJT1NW94.SGD","SRPT","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD"],"gpt_icon":0},{"id":"2537938403","title":"Sarepta Therapeutics Inc - Mhra Allows Dosing to Continue in UK Envision Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2537938403","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537938403?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:30","pubTimestamp":1747830601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nTUAX6SGJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","SRPT","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4585"],"gpt_icon":0},{"id":"2537293847","title":"Sarepta Provides Update on UK Dosing in Envision Study of Elevidys for the Treatment of Duchenne Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2537293847","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537293847?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:30","pubTimestamp":1747830601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nTUAX6SGJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","SRPT","IE00BJJMRZ35.SGD","IE0009355771.USD","IE0002141913.USD","BK4585","IE00B2B36J28.USD","BK4139"],"gpt_icon":0},{"id":"2537640425","title":"Sarepta Shares Higher After J.P. Morgan Note","url":"https://stock-news.laohu8.com/highlight/detail?id=2537640425","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537640425?lang=en_us&edition=fundamental","pubTime":"2025-05-21 03:01","pubTimestamp":1747767660,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics shares were higher after J.P. Morgan reduced its December 2025 price target to $84 from $169 and maintained its overweight rating.The stock was up 4% to $39.55 Tuesday and is down about 67% this year.Sarepta shares closed at $63.66 on May 6 and fell sharply after the company lowered full-year guidance. J.P. Morgan's research note said \"Our Overweight rating on SRPT shares is based on valuation disconnect on the potential of Elevidys .\"","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1363072403.SGD","BK4585","LU2347655156.SGD","BK4534","LU1732799900.SGD","BK4139","IE00BJT1NW94.SGD","LU0225283273.USD","IE0009355771.USD","LU0106261372.USD","BK4127","BK4504","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE00BZ1G4Q59.USD","LU0158827781.USD","LU0795875169.SGD","LU1732800096.USD","LU2089284900.SGD","LU1989772923.USD","LU0006306889.USD","LU1720051017.SGD","LU1162221912.USD","LU1074936037.SGD","BK4581","LU0267386448.USD","IE00BKVL7J92.USD","LU2133065610.SGD","LU2271345857.HKD","LU0795875086.SGD","IE0002141913.USD","BK4516","LU1720051108.HKD","BK4588","LU0912757837.SGD","LU1989772840.SGD","LU2357305700.SGD","LU0320765646.SGD","LU2089283258.USD","SRPT","LU0971096721.USD","LU0098860793.USD","LU2028103732.USD","LU2111349929.HKD","LU0314104364.USD","IE00BFTCPJ56.SGD","LU1548497426.USD","LU0158827948.USD","LU1668664300.SGD","LU2023251221.USD"],"gpt_icon":0},{"id":"2536436776","title":"Sarepta Therapeutics Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2536436776","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536436776?lang=en_us&edition=fundamental","pubTime":"2025-05-20 21:43","pubTimestamp":1747748580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SRPT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 20, 2025 09:43 ET (13:43 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRPT"],"gpt_icon":0},{"id":"2536615292","title":"Buy Rating on Sarepta Therapeutics: Valuation Disconnect and Growth Potential Highlighted by Elevidys Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2536615292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536615292?lang=en_us&edition=fundamental","pubTime":"2025-05-20 18:16","pubTimestamp":1747736192,"startTime":"0","endTime":"0","summary":"Analyst Anupam Rama of J.P. Morgan maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), reducing the price target to $84.00. A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-sarepta-therapeutics-valuation-disconnect-and-growth-potential-highlighted-by-elevidys-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-sarepta-therapeutics-valuation-disconnect-and-growth-potential-highlighted-by-elevidys-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SRPT"],"gpt_icon":0},{"id":"2536663907","title":"Sarepta Therapeutics Inc : JP Morgan Cuts Target Price to $84 From $169","url":"https://stock-news.laohu8.com/highlight/detail?id=2536663907","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536663907?lang=en_us&edition=fundamental","pubTime":"2025-05-20 11:04","pubTimestamp":1747710260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nFWN3RR2G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B2B36J28.USD","BK4585","IE0009355771.USD","IE0002141913.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4139","IE00BFTCPJ56.SGD","SRPT"],"gpt_icon":0},{"id":"2535315506","title":"Sarepta Reports New Elevidys Data from Two Separate Studies in Duchenne Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2535315506","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535315506?lang=en_us&edition=fundamental","pubTime":"2025-05-16 21:56","pubTimestamp":1747403811,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics  said Friday that new data from two separate studies of its gene therapy Elevidys showed high levels of protein expression in toddlers and statistically significant functional improvements in older boys with Duchenne muscular dystrophy.In the Endeavor study, children who were 2 years old at the time of treatment showed an average protein expression level of nearly 94% twelve weeks after dosing, the company said.The safety profile in this group aligned with earlier findings, with nausea and vomiting as the most common side effects, Sarepta said, adding that elevated liver enzymes occurred in two participants but resolved with steroids.Sarepta said that in the Embark trial, boys aged 8 to 9 years who were treated after receiving a placebo in the earlier phase showed statistically significant gains one year after treatment.Compared to an external control group, they improved by 4.75 points on the North Star Ambulatory Assessment, reduced time to rise by nearly 7 secon","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFTCPJ56.SGD","BK4585","IE00BJT1NW94.SGD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4139","SRPT"],"gpt_icon":0},{"id":"2535539036","title":"Sarepta Therapeutics Shares New Protein Expression and Safety Results From Endeavor in Participants 2 Years Old at Time of Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2535539036","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535539036?lang=en_us&edition=fundamental","pubTime":"2025-05-16 21:02","pubTimestamp":1747400559,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nFWN3RO1PP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B2B36J28.USD","BK4585","IE0009355771.USD","BK4139","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","SRPT","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2535390328","title":"Sarepta Therapeutics Inc: Treatment With Elevidys Demonstrated Mean Expression of 93.87% of Normal, as Measured by Western Blot","url":"https://stock-news.laohu8.com/highlight/detail?id=2535390328","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535390328?lang=en_us&edition=fundamental","pubTime":"2025-05-16 21:02","pubTimestamp":1747400559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nFWN3RO1PP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJJMRZ35.SGD","IE0002141913.USD","SRPT","IE0009355771.USD","BK4139","BK4585","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2535042410","title":"Sarepta Therapeutics: Hold Rating Amid Limited Financial Gains from ELEVIDYS Approval and Market Adoption Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2535042410","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535042410?lang=en_us&edition=fundamental","pubTime":"2025-05-14 18:58","pubTimestamp":1747220283,"startTime":"0","endTime":"0","summary":"In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Hold rating on Sarepta Therapeutics (SRPT – Research Report), with a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sarepta-therapeutics-hold-rating-amid-limited-financial-gains-from-elevidys-approval-and-market-adoption-concerns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sarepta-therapeutics-hold-rating-amid-limited-financial-gains-from-elevidys-approval-and-market-adoption-concerns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SRPT"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SRPT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"SRPT","fiscalQuarterEnding":"2025/03","expectedEps":-0.87,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-3.84},{"market":"US","date":"2025-02-26","symbol":"SRPT","fiscalQuarterEnding":"2024/12","expectedEps":1.87,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"post","actualEps":1.5},{"market":"US","date":"2025-01-13","symbol":"SRPT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-06","symbol":"SRPT","fiscalQuarterEnding":"2024/09","expectedEps":-0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":0.24},{"market":"US","date":"2024-08-07","symbol":"SRPT","fiscalQuarterEnding":"2024/06","expectedEps":0,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SRPT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SRPT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2593,"buy":0.2593,"hold":0.4444,"sell":0.037,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2593,"analysts":27,"updateTime":1750478400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SRPT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SRPT","date":"2025-07-03","current":-7.216826,"percent":0.800991,"low":-24.046044,"twenty":-18.58593,"median":-12.755864,"eighty":-7.468209,"high":883.870215,"avg":39.098809,"sd":161.184983,"marketCap":1792573063},"quantilePoints":[{"date":"2020-07-10","current":-20.07135,"twenty":-33.486343,"median":-13.805115,"eighty":-8.610125,"marketCap":13165279874},{"date":"2020-07-17","current":-19.916781,"twenty":-33.486343,"median":-13.844021,"eighty":-8.610125,"marketCap":13063894507},{"date":"2020-07-24","current":-18.860957,"twenty":-33.486343,"median":-13.853283,"eighty":-8.610125,"marketCap":12371354460},{"date":"2020-07-31","current":-18.253383,"twenty":-33.486343,"median":-13.927708,"eighty":-8.610125,"marketCap":11972831978},{"date":"2020-08-07","current":-23.53204,"twenty":-33.486343,"median":-13.980427,"eighty":-8.610125,"marketCap":12480005822},{"date":"2020-08-14","current":-23.240425,"twenty":-33.486343,"median":-14.163014,"eighty":-8.610125,"marketCap":12325350155},{"date":"2020-08-21","current":-21.01112,"twenty":-33.486343,"median":-14.23852,"eighty":-8.610125,"marketCap":11143058605},{"date":"2020-08-28","current":-21.828236,"twenty":-33.486343,"median":-14.284733,"eighty":-8.610125,"marketCap":11576408495},{"date":"2020-09-04","current":-19.650741,"twenty":-33.486343,"median":-14.363615,"eighty":-8.610125,"marketCap":10421593841},{"date":"2020-09-11","current":-19.344323,"twenty":-33.486343,"median":-14.402541,"eighty":-8.610125,"marketCap":10259087632},{"date":"2020-09-18","current":-21.394513,"twenty":-33.486343,"median":-14.421864,"eighty":-8.610125,"marketCap":11346387629},{"date":"2020-09-25","current":-21.316058,"twenty":-33.486343,"median":-14.505536,"eighty":-8.610125,"marketCap":11304779760},{"date":"2020-10-02","current":-19.952719,"twenty":-33.486343,"median":-14.610908,"eighty":-8.610125,"marketCap":10581744887},{"date":"2020-10-09","current":-21.253887,"twenty":-33.486343,"median":-14.616093,"eighty":-8.610125,"marketCap":11271807485},{"date":"2020-10-16","current":-21.082174,"twenty":-33.486343,"median":-14.651322,"eighty":-8.610125,"marketCap":11180741204},{"date":"2020-10-23","current":-20.387922,"twenty":-33.486343,"median":-14.729027,"eighty":-8.610125,"marketCap":10812550807},{"date":"2020-10-30","current":-20.11851,"twenty":-33.486343,"median":-14.786835,"eighty":-8.610125,"marketCap":10669670952},{"date":"2020-11-06","current":-16.512876,"twenty":-33.486343,"median":-14.862496,"eighty":-8.610125,"marketCap":9916213234},{"date":"2020-11-13","current":-18.581256,"twenty":-33.486343,"median":-14.911777,"eighty":-8.610125,"marketCap":11158304563},{"date":"2020-11-20","current":-17.238255,"twenty":-33.486343,"median":-15.026153,"eighty":-8.610125,"marketCap":10351813243},{"date":"2020-11-27","current":-18.285586,"twenty":-33.486343,"median":-15.026153,"eighty":-8.610125,"marketCap":10980750211},{"date":"2020-12-04","current":-20.779732,"twenty":-33.486343,"median":-15.026153,"eighty":-8.610125,"marketCap":12478519805},{"date":"2020-12-11","current":-21.976869,"twenty":-33.486343,"median":-15.026153,"eighty":-8.610125,"marketCap":13197417645},{"date":"2020-12-18","current":-23.049168,"twenty":-33.486343,"median":-15.026153,"eighty":-8.610125,"marketCap":13841348093},{"date":"2020-12-24","current":-23.000547,"twenty":-33.486343,"median":-15.026153,"eighty":-8.610125,"marketCap":13812150266},{"date":"2020-12-31","current":-22.403949,"twenty":-33.486343,"median":-15.026153,"eighty":-8.610125,"marketCap":13453885042},{"date":"2021-01-08","current":-10.81366,"twenty":-33.486343,"median":-15.012881,"eighty":-8.610125,"marketCap":6493754473},{"date":"2021-01-15","current":-11.868876,"twenty":-33.486343,"median":-14.922795,"eighty":-8.610125,"marketCap":7127426224},{"date":"2021-01-22","current":-12.909637,"twenty":-33.486343,"median":-14.922795,"eighty":-8.664246,"marketCap":7752417540},{"date":"2021-01-29","current":-11.74798,"twenty":-33.486343,"median":-14.922795,"eighty":-8.718316,"marketCap":7054826223},{"date":"2021-02-05","current":-12.587684,"twenty":-33.486343,"median":-14.922795,"eighty":-8.770477,"marketCap":7559080580},{"date":"2021-02-12","current":-11.967433,"twenty":-33.486343,"median":-14.922795,"eighty":-8.814829,"marketCap":7186611008},{"date":"2021-02-19","current":-11.219715,"twenty":-33.486343,"median":-14.922795,"eighty":-8.878284,"marketCap":6737595782},{"date":"2021-02-26","current":-11.440482,"twenty":-33.486343,"median":-14.922795,"eighty":-8.921374,"marketCap":6870169697},{"date":"2021-03-05","current":-12.152565,"twenty":-33.487457,"median":-14.922795,"eighty":-8.944194,"marketCap":6734076319},{"date":"2021-03-12","current":-12.393351,"twenty":-33.487457,"median":-14.922795,"eighty":-8.982397,"marketCap":6867503000},{"date":"2021-03-19","current":-11.844415,"twenty":-33.487457,"median":-14.922795,"eighty":-9.166229,"marketCap":6563321937},{"date":"2021-03-26","current":-10.717877,"twenty":-33.486343,"median":-14.922795,"eighty":-9.266092,"marketCap":5939075683},{"date":"2021-04-01","current":-10.922832,"twenty":-33.486343,"median":-14.922795,"eighty":-9.360693,"marketCap":6052647203},{"date":"2021-04-09","current":-10.110177,"twenty":-33.487457,"median":-14.922795,"eighty":-9.439745,"marketCap":5602332157},{"date":"2021-04-16","current":-10.290767,"twenty":-33.487457,"median":-14.922795,"eighty":-9.439745,"marketCap":5702402167},{"date":"2021-04-23","current":-10.210207,"twenty":-33.487457,"median":-14.922795,"eighty":-9.477548,"marketCap":5657761387},{"date":"2021-04-30","current":-10.195814,"twenty":-33.487457,"median":-14.922795,"eighty":-9.604074,"marketCap":5649785969},{"date":"2021-05-07","current":-8.451354,"twenty":-33.487457,"median":-14.922795,"eighty":-9.718915,"marketCap":5948790057},{"date":"2021-05-14","current":-8.619089,"twenty":-33.487457,"median":-14.922795,"eighty":-9.718915,"marketCap":6066856428},{"date":"2021-05-21","current":-9.01916,"twenty":-33.487457,"median":-14.922795,"eighty":-9.718915,"marketCap":6348460678},{"date":"2021-05-28","current":-8.573756,"twenty":-33.487457,"median":-14.922795,"eighty":-9.718915,"marketCap":6034946598},{"date":"2021-06-04","current":-8.270019,"twenty":-33.487457,"median":-14.922795,"eighty":-9.718915,"marketCap":5821150737},{"date":"2021-06-11","current":-9.746768,"twenty":-33.487457,"median":-14.922795,"eighty":-9.736714,"marketCap":6860613450},{"date":"2021-06-18","current":-8.993093,"twenty":-33.487457,"median":-14.922795,"eighty":-9.754928,"marketCap":6330112526},{"date":"2021-06-25","current":-9.112095,"twenty":-33.487457,"median":-14.922795,"eighty":-9.754928,"marketCap":6413875830},{"date":"2021-07-02","current":-8.527289,"twenty":-33.487457,"median":-14.922795,"eighty":-9.754928,"marketCap":6002239023},{"date":"2021-07-09","current":-8.279086,"twenty":-33.487457,"median":-14.922795,"eighty":-9.754928,"marketCap":5827532703},{"date":"2021-07-16","current":-7.599079,"twenty":-33.487457,"median":-14.922795,"eighty":-9.754928,"marketCap":5348885253},{"date":"2021-07-23","current":-7.569612,"twenty":-33.487457,"median":-14.922795,"eighty":-9.754928,"marketCap":5328143864},{"date":"2021-07-30","current":-7.681813,"twenty":-33.487457,"median":-14.922795,"eighty":-9.754928,"marketCap":5407120693},{"date":"2021-08-06","current":-10.042387,"twenty":-33.487457,"median":-14.922795,"eighty":-9.78377,"marketCap":6371603389},{"date":"2021-08-13","current":-10.060005,"twenty":-33.487457,"median":-14.922795,"eighty":-9.837079,"marketCap":6382781640},{"date":"2021-08-20","current":-9.477346,"twenty":-33.487457,"median":-14.922795,"eighty":-9.837079,"marketCap":6013100892},{"date":"2021-08-27","current":-9.9027,"twenty":-33.487457,"median":-14.922795,"eighty":-9.866209,"marketCap":6282975823},{"date":"2021-09-03","current":-10.131737,"twenty":-33.487457,"median":-14.922795,"eighty":-9.888388,"marketCap":6428293093},{"date":"2021-09-10","current":-10.126703,"twenty":-33.487457,"median":-14.922795,"eighty":-9.898273,"marketCap":6425099307},{"date":"2021-09-17","current":-10.870444,"twenty":-33.487457,"median":-14.922795,"eighty":-9.947169,"marketCap":6896981212},{"date":"2021-09-24","current":-11.397732,"twenty":-33.487457,"median":-14.8974,"eighty":-9.947169,"marketCap":7231530312},{"date":"2021-10-01","current":-12.087359,"twenty":-33.487457,"median":-14.824584,"eighty":-9.947169,"marketCap":7669079016},{"date":"2021-10-08","current":-12.511455,"twenty":-33.487457,"median":-14.768842,"eighty":-9.947169,"marketCap":7938155500},{"date":"2021-10-15","current":-11.536802,"twenty":-33.487457,"median":-14.670631,"eighty":-9.947169,"marketCap":7319766529},{"date":"2021-10-22","current":-10.995522,"twenty":-33.487457,"median":-14.665323,"eighty":-9.947169,"marketCap":6976340020},{"date":"2021-10-29","current":-10.843416,"twenty":-33.487457,"median":-14.665323,"eighty":-9.947169,"marketCap":6879832824},{"date":"2021-11-05","current":-15.92984,"twenty":-33.487457,"median":-14.721064,"eighty":-9.947169,"marketCap":7743750317},{"date":"2021-11-12","current":-15.21512,"twenty":-33.487457,"median":-14.780826,"eighty":-9.947169,"marketCap":7396313414},{"date":"2021-11-19","current":-14.33202,"twenty":-33.487457,"median":-14.79804,"eighty":-9.947169,"marketCap":6967024209},{"date":"2021-11-26","current":-14.26216,"twenty":-33.487457,"median":-14.79804,"eighty":-9.947169,"marketCap":6933064211},{"date":"2021-12-03","current":-14.061537,"twenty":-33.487457,"median":-14.824584,"eighty":-9.981016,"marketCap":6835538063},{"date":"2021-12-10","current":-15.313641,"twenty":-33.487457,"median":-14.868557,"eighty":-10.040359,"marketCap":7444205719},{"date":"2021-12-17","current":-15.745339,"twenty":-33.487457,"median":-14.922795,"eighty":-10.083787,"marketCap":7654061092},{"date":"2021-12-23","current":-16.400947,"twenty":-33.487457,"median":-15.025245,"eighty":-10.107223,"marketCap":7972762612},{"date":"2021-12-31","current":-16.130464,"twenty":-33.487457,"median":-15.063476,"eighty":-10.131737,"marketCap":7841276465},{"date":"2022-01-07","current":-15.315432,"twenty":-33.486343,"median":-15.131066,"eighty":-10.17331,"marketCap":7445076489},{"date":"2022-01-14","current":-12.735991,"twenty":-33.486343,"median":-15.131066,"eighty":-10.19531,"marketCap":6191168869},{"date":"2022-01-21","current":-11.369245,"twenty":-33.486343,"median":-15.131066,"eighty":-10.240192,"marketCap":5526771985},{"date":"2022-01-28","current":-12.48342,"twenty":-33.486343,"median":-15.131066,"eighty":-10.273225,"marketCap":6068390415},{"date":"2022-02-04","current":-13.096038,"twenty":-33.486343,"median":-15.131066,"eighty":-10.298301,"marketCap":6366193474},{"date":"2022-02-11","current":-14.371428,"twenty":-33.486343,"median":-15.131066,"eighty":-10.376622,"marketCap":6986181131},{"date":"2022-02-18","current":-13.359356,"twenty":-33.486343,"median":-15.131066,"eighty":-10.466117,"marketCap":6494196544},{"date":"2022-02-25","current":-13.619091,"twenty":-33.486343,"median":-15.131066,"eighty":-10.518593,"marketCap":6620458075},{"date":"2022-03-04","current":-16.515095,"twenty":-33.486343,"median":-15.218077,"eighty":-10.572334,"marketCap":6916191383},{"date":"2022-03-11","current":-16.200858,"twenty":-33.486343,"median":-15.314536,"eighty":-10.632153,"marketCap":6784595503},{"date":"2022-03-18","current":-16.864709,"twenty":-33.486343,"median":-15.415744,"eighty":-10.710562,"marketCap":7062602692},{"date":"2022-03-25","current":-16.080158,"twenty":-33.486343,"median":-15.506708,"eighty":-10.766201,"marketCap":6734048742},{"date":"2022-04-01","current":-17.181026,"twenty":-33.486343,"median":-15.57248,"eighty":-10.834767,"marketCap":7195070067},{"date":"2022-04-08","current":-18.300623,"twenty":-33.486343,"median":-15.646479,"eighty":-10.859691,"marketCap":7663934856},{"date":"2022-04-14","current":-16.950031,"twenty":-33.486343,"median":-15.713597,"eighty":-10.886449,"marketCap":7098334024},{"date":"2022-04-22","current":-15.899108,"twenty":-33.486343,"median":-15.810262,"eighty":-10.922549,"marketCap":6658228599},{"date":"2022-04-29","current":-15.110477,"twenty":-33.486343,"median":-15.820202,"eighty":-10.969616,"marketCap":6327965648},{"date":"2022-05-06","current":-17.217729,"twenty":-33.486343,"median":-15.860447,"eighty":-11.021286,"marketCap":6139067423},{"date":"2022-05-13","current":-16.189475,"twenty":-33.486343,"median":-15.909513,"eighty":-11.07095,"marketCap":5772438397},{"date":"2022-05-20","current":-17.455774,"twenty":-33.486343,"median":-15.977123,"eighty":-11.111984,"marketCap":6223943355},{"date":"2022-05-27","current":-18.319605,"twenty":-33.486343,"median":-16.088482,"eighty":-11.170601,"marketCap":6531946738},{"date":"2022-06-03","current":-17.909776,"twenty":-33.486343,"median":-16.140631,"eighty":-11.179205,"marketCap":6385820133},{"date":"2022-06-10","current":-16.969868,"twenty":-33.486343,"median":-16.198799,"eighty":-11.221801,"marketCap":6050691453},{"date":"2022-06-17","current":-16.434882,"twenty":-33.486343,"median":-16.24212,"eighty":-11.287651,"marketCap":5859939358},{"date":"2022-06-24","current":-18.459487,"twenty":-33.487457,"median":-16.29347,"eighty":-11.319146,"marketCap":6581822286},{"date":"2022-07-01","current":-18.579736,"twenty":-33.487457,"median":-16.400947,"eighty":-11.396024,"marketCap":6624697757},{"date":"2022-07-08","current":-19.747872,"twenty":-33.487457,"median":-16.442244,"eighty":-11.453098,"marketCap":7041202331},{"date":"2022-07-15","current":-20.51354,"twenty":-33.487457,"median":-16.515095,"eighty":-11.483769,"marketCap":7314205329},{"date":"2022-07-22","current":-20.611703,"twenty":-33.487457,"median":-16.735684,"eighty":-11.570453,"marketCap":7349205714},{"date":"2022-07-29","current":-22.810546,"twenty":-33.487457,"median":-16.8079,"eighty":-11.586846,"marketCap":8133214324},{"date":"2022-08-05","current":-18.324864,"twenty":-33.487457,"median":-16.864709,"eighty":-11.632442,"marketCap":9283944199},{"date":"2022-08-12","current":-18.839938,"twenty":-33.487457,"median":-16.954193,"eighty":-11.749575,"marketCap":9544896413},{"date":"2022-08-19","current":-18.642896,"twenty":-33.487457,"median":-17.124838,"eighty":-11.790115,"marketCap":9445069056},{"date":"2022-08-26","current":-19.339455,"twenty":-33.487457,"median":-17.238255,"eighty":-11.839013,"marketCap":9797967519},{"date":"2022-09-02","current":-18.905618,"twenty":-33.487457,"median":-17.328348,"eighty":-11.85378,"marketCap":9578172198},{"date":"2022-09-09","current":-20.47158,"twenty":-33.487457,"median":-17.439311,"eighty":-11.869884,"marketCap":10371536983},{"date":"2022-09-16","current":-19.35674,"twenty":-33.487457,"median":-17.55145,"eighty":-11.869884,"marketCap":9806724305},{"date":"2022-09-23","current":-18.699934,"twenty":-33.487457,"median":-17.61038,"eighty":-11.869884,"marketCap":9473966448},{"date":"2022-09-30","current":-19.106117,"twenty":-33.487457,"median":-17.720715,"eighty":-11.882952,"marketCap":9679750912},{"date":"2022-10-07","current":-19.244391,"twenty":-33.487457,"median":-17.816521,"eighty":-11.882952,"marketCap":9749805198},{"date":"2022-10-14","current":-19.436248,"twenty":-33.487457,"median":-17.853332,"eighty":-11.882952,"marketCap":9847005519},{"date":"2022-10-21","current":-19.479458,"twenty":-33.487457,"median":-18.036331,"eighty":-11.882952,"marketCap":9868897483},{"date":"2022-10-28","current":-19.925395,"twenty":-33.487457,"median":-18.253383,"eighty":-11.882952,"marketCap":10094822554},{"date":"2022-11-04","current":-12.701188,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":9096908350},{"date":"2022-11-11","current":-13.101968,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":9383957374},{"date":"2022-11-18","current":-13.727039,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":9831648512},{"date":"2022-11-25","current":-14.042026,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":10057249732},{"date":"2022-12-02","current":-15.47356,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":11082550220},{"date":"2022-12-09","current":-14.506539,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":10389945695},{"date":"2022-12-16","current":-15.143866,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":10846415090},{"date":"2022-12-23","current":-15.927042,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":11407345751},{"date":"2022-12-30","current":-15.881694,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":11374866198},{"date":"2023-01-06","current":-14.985759,"twenty":-33.487457,"median":-18.191555,"eighty":-11.882952,"marketCap":10733175567},{"date":"2023-01-13","current":-15.528713,"twenty":-33.456944,"median":-17.909776,"eighty":-11.882952,"marketCap":11122052379},{"date":"2023-01-20","current":-15.960134,"twenty":-33.300551,"median":-17.845559,"eighty":-11.882952,"marketCap":11431047046},{"date":"2023-01-27","current":-15.061748,"twenty":-32.919719,"median":-17.811613,"eighty":-11.882952,"marketCap":10787600764},{"date":"2023-02-03","current":-14.584979,"twenty":-31.722083,"median":-17.704757,"eighty":-11.882952,"marketCap":10446126544},{"date":"2023-02-10","current":-14.762695,"twenty":-30.985635,"median":-17.595871,"eighty":-11.882952,"marketCap":10573411279},{"date":"2023-02-17","current":-15.267654,"twenty":-29.901275,"median":-17.534969,"eighty":-11.882952,"marketCap":10935075492},{"date":"2023-02-24","current":-15.082584,"twenty":-29.05432,"median":-17.439311,"eighty":-11.882952,"marketCap":10802523802},{"date":"2023-03-03","current":-19.4614,"twenty":-28.510706,"median":-17.360065,"eighty":-11.882952,"marketCap":13690861124},{"date":"2023-03-10","current":-17.999387,"twenty":-28.077567,"median":-17.360065,"eighty":-11.882952,"marketCap":12662352889},{"date":"2023-03-17","current":-15.344252,"twenty":-27.752664,"median":-17.333332,"eighty":-11.882952,"marketCap":10794497470},{"date":"2023-03-24","current":-16.282242,"twenty":-27.473482,"median":-17.241552,"eighty":-11.882952,"marketCap":11454361608},{"date":"2023-03-31","current":-17.23774,"twenty":-27.348211,"median":-17.180972,"eighty":-11.887084,"marketCap":12126543209},{"date":"2023-04-06","current":-17.201471,"twenty":-27.162667,"median":-17.180972,"eighty":-11.887084,"marketCap":12101028462},{"date":"2023-04-14","current":-15.598135,"twenty":-26.652324,"median":-17.135243,"eighty":-11.882952,"marketCap":10973100697},{"date":"2023-04-21","current":-15.791986,"twenty":-26.082852,"median":-16.995814,"eighty":-11.882952,"marketCap":11109472618},{"date":"2023-04-28","current":-16.17049,"twenty":-25.551433,"median":-16.893792,"eighty":-11.882952,"marketCap":11375745723},{"date":"2023-05-05","current":-10.872457,"twenty":-25.030309,"median":-16.827533,"eighty":-11.85378,"marketCap":12125160030},{"date":"2023-05-12","current":-10.039712,"twenty":-24.79041,"median":-16.763727,"eighty":-11.839013,"marketCap":11196467970},{"date":"2023-05-19","current":-12.230575,"twenty":-24.588135,"median":-16.652443,"eighty":-11.832204,"marketCap":13639757112},{"date":"2023-05-26","current":-10.763039,"twenty":-24.230664,"median":-16.515095,"eighty":-11.806325,"marketCap":12003135296},{"date":"2023-06-02","current":-10.380495,"twenty":-24.049078,"median":-16.443073,"eighty":-11.77077,"marketCap":11576514470},{"date":"2023-06-09","current":-10.51664,"twenty":-23.8991,"median":-16.413486,"eighty":-11.709243,"marketCap":11728346773},{"date":"2023-06-16","current":-10.992733,"twenty":-23.737208,"median":-16.354855,"eighty":-11.607339,"marketCap":12259294089},{"date":"2023-06-23","current":-10.350426,"twenty":-23.536481,"median":-16.290064,"eighty":-11.554763,"marketCap":11542980955},{"date":"2023-06-30","current":-9.374853,"twenty":-23.474389,"median":-16.257046,"eighty":-11.479198,"marketCap":10455004700},{"date":"2023-07-07","current":-9.187757,"twenty":-23.38476,"median":-16.200858,"eighty":-11.461589,"marketCap":10246351720},{"date":"2023-07-14","current":-9.062469,"twenty":-23.039444,"median":-16.181079,"eighty":-11.394645,"marketCap":10106628742},{"date":"2023-07-21","current":-8.754262,"twenty":-22.805833,"median":-16.140052,"eighty":-11.314331,"marketCap":9762910216},{"date":"2023-07-28","current":-8.813564,"twenty":-22.54964,"median":-16.080158,"eighty":-11.279049,"marketCap":9829045759},{"date":"2023-08-04","current":-11.031997,"twenty":-22.46109,"median":-15.990696,"eighty":-11.220237,"marketCap":10013490129},{"date":"2023-08-11","current":-10.893262,"twenty":-22.365189,"median":-15.944171,"eighty":-11.17764,"marketCap":9887563612},{"date":"2023-08-18","current":-11.398874,"twenty":-22.213166,"median":-15.909513,"eighty":-11.172295,"marketCap":10346495809},{"date":"2023-08-25","current":-11.920929,"twenty":-22.033995,"median":-15.843668,"eighty":-11.172295,"marketCap":10820352632},{"date":"2023-09-01","current":-12.435789,"twenty":-21.874764,"median":-15.810262,"eighty":-11.172295,"marketCap":11287679931},{"date":"2023-09-07","current":-12.625908,"twenty":-21.804551,"median":-15.797541,"eighty":-11.172078,"marketCap":11460245899},{"date":"2023-09-15","current":-12.30322,"twenty":-21.692821,"median":-15.730942,"eighty":-11.171862,"marketCap":11167350147},{"date":"2023-09-22","current":-12.28575,"twenty":-21.543114,"median":-15.659417,"eighty":-11.171645,"marketCap":11151492734},{"date":"2023-09-29","current":-12.700927,"twenty":-21.385826,"median":-15.649721,"eighty":-11.170968,"marketCap":11528339498},{"date":"2023-10-06","current":-12.476896,"twenty":-21.308219,"median":-15.598135,"eighty":-11.170723,"marketCap":11324991491},{"date":"2023-10-13","current":-12.045276,"twenty":-21.147899,"median":-15.566211,"eighty":-11.170723,"marketCap":10933220103},{"date":"2023-10-20","current":-11.612629,"twenty":-21.079862,"median":-15.520133,"eighty":-11.170723,"marketCap":10540515926},{"date":"2023-10-23","current":-11.427649,"twenty":-21.068127,"median":-15.513919,"eighty":-11.170723,"marketCap":10372613902},{"date":"2023-11-03","current":-10.528937,"twenty":-20.936576,"median":-15.488267,"eighty":-11.099283,"marketCap":7274189914},{"date":"2023-11-10","current":-10.717147,"twenty":-20.877303,"median":-15.426491,"eighty":-11.063183,"marketCap":7404219801},{"date":"2023-11-17","current":-11.235741,"twenty":-20.779011,"median":-15.386996,"eighty":-11.038163,"marketCap":7762503589},{"date":"2023-11-24","current":-11.220846,"twenty":-20.664142,"median":-15.3405,"eighty":-11.038163,"marketCap":7752213454},{"date":"2023-12-01","current":-11.005556,"twenty":-20.59428,"median":-15.316056,"eighty":-11.023641,"marketCap":7603474231},{"date":"2023-12-08","current":-11.970979,"twenty":-20.499735,"median":-15.29952,"eighty":-11.023641,"marketCap":8270462067},{"date":"2023-12-14","current":-12.47197,"twenty":-20.414968,"median":-15.277459,"eighty":-11.022929,"marketCap":8616584786},{"date":"2023-12-22","current":-12.287822,"twenty":-20.322789,"median":-15.250912,"eighty":-11.014716,"marketCap":8489361300},{"date":"2023-12-29","current":-13.239705,"twenty":-20.231993,"median":-15.216098,"eighty":-11.011875,"marketCap":9146994468},{"date":"2024-01-05","current":-12.765795,"twenty":-20.179783,"median":-15.156008,"eighty":-11.010455,"marketCap":8819581084},{"date":"2024-01-12","current":-15.714872,"twenty":-20.100122,"median":-15.110477,"eighty":-11.010455,"marketCap":10857027796},{"date":"2024-01-19","current":-15.81507,"twenty":-19.947254,"median":-15.108301,"eighty":-11.009034,"marketCap":10926252340},{"date":"2024-01-26","current":-16.251068,"twenty":-19.907269,"median":-15.110477,"eighty":-11.010455,"marketCap":11227472653},{"date":"2024-02-02","current":-16.63155,"twenty":-19.806572,"median":-15.110477,"eighty":-11.010455,"marketCap":11490338827},{"date":"2024-02-09","current":-17.247634,"twenty":-19.70754,"median":-15.110477,"eighty":-11.010455,"marketCap":11915976225},{"date":"2024-02-16","current":-16.91048,"twenty":-19.657484,"median":-15.110477,"eighty":-11.010455,"marketCap":11683044990},{"date":"2024-02-23","current":-18.249616,"twenty":-19.552709,"median":-15.110477,"eighty":-11.010455,"marketCap":12608221665},{"date":"2024-03-01","current":-22.367193,"twenty":-19.518867,"median":-15.127171,"eighty":-11.011875,"marketCap":11988301184},{"date":"2024-03-08","current":-21.149893,"twenty":-19.518867,"median":-15.127171,"eighty":-11.011875,"marketCap":11335856419},{"date":"2024-03-15","current":-21.671724,"twenty":-19.518867,"median":-15.127171,"eighty":-11.011875,"marketCap":11615545541},{"date":"2024-03-22","current":-21.878355,"twenty":-19.518867,"median":-15.127171,"eighty":-11.011875,"marketCap":11726294925},{"date":"2024-03-28","current":-22.804691,"twenty":-19.518867,"median":-15.127171,"eighty":-11.011875,"marketCap":12222790044},{"date":"2024-04-05","current":-22.027199,"twenty":-19.511986,"median":-15.110477,"eighty":-11.010455,"marketCap":11806072023},{"date":"2024-04-12","current":-21.79255,"twenty":-19.511986,"median":-15.110477,"eighty":-11.010455,"marketCap":11680305774},{"date":"2024-04-19","current":-20.409174,"twenty":-19.511986,"median":-15.110477,"eighty":-11.010455,"marketCap":10938848035},{"date":"2024-04-26","current":-22.461914,"twenty":-19.518867,"median":-15.127171,"eighty":-11.011875,"marketCap":12039069403},{"date":"2024-05-03","current":730.75928,"twenty":-19.495389,"median":-15.100483,"eighty":-11.001542,"marketCap":12347639552},{"date":"2024-05-10","current":740.101452,"twenty":-19.445465,"median":-15.07282,"eighty":-10.973857,"marketCap":12505494241},{"date":"2024-05-17","current":742.562863,"twenty":-19.389234,"median":-15.060083,"eighty":-10.940505,"marketCap":12547084698},{"date":"2024-05-24","current":711.179876,"twenty":-19.347967,"median":-14.991274,"eighty":-10.914492,"marketCap":12016806371},{"date":"2024-05-31","current":696.187647,"twenty":-19.32434,"median":-14.923253,"eighty":-10.891058,"marketCap":11763482678},{"date":"2024-06-07","current":656.972899,"twenty":-19.250342,"median":-14.895006,"eighty":-10.871652,"marketCap":11100871079},{"date":"2024-06-14","current":699.264411,"twenty":-19.151885,"median":-14.846038,"eighty":-10.850764,"marketCap":11815470750},{"date":"2024-06-21","current":690.873238,"twenty":-19.114413,"median":-14.77176,"eighty":-10.837374,"marketCap":11673685101},{"date":"2024-06-28","current":883.646451,"twenty":-19.062416,"median":-14.738183,"eighty":-10.818876,"marketCap":14930974077},{"date":"2024-07-05","current":856.514992,"twenty":-19.012825,"median":-14.719798,"eighty":-10.773256,"marketCap":14472533812},{"date":"2024-07-12","current":850.920876,"twenty":-18.927625,"median":-14.62665,"eighty":-10.744454,"marketCap":14378010046},{"date":"2024-07-15","current":850.920876,"twenty":-18.908766,"median":-14.624593,"eighty":-10.731945,"marketCap":14378010046},{"date":"2024-08-02","current":805.608542,"twenty":-18.839555,"median":-14.506156,"eighty":-10.704978,"marketCap":13612367541},{"date":"2024-08-09","current":275.027337,"twenty":-18.813398,"median":-14.459064,"eighty":-10.653503,"marketCap":13007967957},{"date":"2024-08-16","current":268.857369,"twenty":-18.813398,"median":-14.360962,"eighty":-10.59605,"marketCap":12716146975},{"date":"2024-08-23","current":285.169474,"twenty":-18.813398,"median":-14.330229,"eighty":-10.577226,"marketCap":13487660617},{"date":"2024-08-30","current":276.741217,"twenty":-18.813398,"median":-14.330229,"eighty":-10.533579,"marketCap":13089029341},{"date":"2024-09-06","current":269.724391,"twenty":-18.813398,"median":-14.330229,"eighty":-10.51664,"marketCap":12757154499},{"date":"2024-09-13","current":252.726733,"twenty":-18.813398,"median":-14.330229,"eighty":-10.472775,"marketCap":11953216303},{"date":"2024-09-20","current":256.275473,"twenty":-18.813398,"median":-14.330229,"eighty":-10.409727,"marketCap":12121061051},{"date":"2024-09-27","current":251.718569,"twenty":-18.813398,"median":-14.330229,"eighty":-10.380495,"marketCap":11905533136},{"date":"2024-10-04","current":239.459285,"twenty":-18.813398,"median":-14.330229,"eighty":-10.355264,"marketCap":11325705825},{"date":"2024-10-11","current":246.818888,"twenty":-18.813398,"median":-14.330229,"eighty":-10.29911,"marketCap":11673792944},{"date":"2024-10-18","current":250.528934,"twenty":-18.813398,"median":-14.330229,"eighty":-10.273535,"marketCap":11849266999},{"date":"2024-10-25","current":266.195814,"twenty":-18.813398,"median":-14.330229,"eighty":-10.210207,"marketCap":12590263414},{"date":"2024-10-31","current":257.646577,"twenty":-18.813398,"median":-14.330229,"eighty":-10.148318,"marketCap":12185910158},{"date":"2024-11-08","current":94.40253,"twenty":-18.814187,"median":-14.33202,"eighty":-10.124434,"marketCap":11502476253},{"date":"2024-11-15","current":85.536124,"twenty":-18.814187,"median":-14.33202,"eighty":-10.081418,"marketCap":10422149011},{"date":"2024-11-22","current":86.625806,"twenty":-18.814187,"median":-14.33202,"eighty":-10.039712,"marketCap":10554921325},{"date":"2024-11-29","current":104.531086,"twenty":-18.814187,"median":-14.33202,"eighty":-9.994314,"marketCap":12736590131},{"date":"2024-12-06","current":98.996441,"twenty":-18.814187,"median":-14.33202,"eighty":-9.880803,"marketCap":12062221402},{"date":"2024-12-13","current":97.577503,"twenty":-18.814187,"median":-14.33202,"eighty":-9.825179,"marketCap":11889330835},{"date":"2024-12-20","current":93.657783,"twenty":-18.814187,"median":-14.236415,"eighty":-9.703473,"marketCap":11411732585},{"date":"2024-12-27","current":96.715165,"twenty":-18.814187,"median":-14.1595,"eighty":-9.485199,"marketCap":11784259220},{"date":"2025-01-03","current":97.279604,"twenty":-18.814187,"median":-14.062861,"eighty":-9.459492,"marketCap":11853033368},{"date":"2025-01-10","current":98.988602,"twenty":-18.814976,"median":-13.918522,"eighty":-9.374471,"marketCap":12061266205},{"date":"2025-01-17","current":91.768478,"twenty":-18.814976,"median":-13.725814,"eighty":-9.290713,"marketCap":11181530229},{"date":"2025-01-24","current":93.399082,"twenty":-18.814976,"median":-13.6749,"eighty":-9.174719,"marketCap":11380211101},{"date":"2025-01-31","current":89.722385,"twenty":-18.814976,"median":-13.611926,"eighty":-9.085121,"marketCap":10932223942},{"date":"2025-02-07","current":87.887956,"twenty":-18.814976,"median":-13.459852,"eighty":-9.049606,"marketCap":10708707961},{"date":"2025-02-14","current":85.810504,"twenty":-18.814976,"median":-13.307151,"eighty":-9.020125,"marketCap":10455580889},{"date":"2025-02-21","current":84.987363,"twenty":-18.814976,"median":-13.243105,"eighty":-8.988436,"marketCap":10355285256},{"date":"2025-02-28","current":42.452846,"twenty":-18.814976,"median":-13.154716,"eighty":-8.920632,"marketCap":9986565117},{"date":"2025-03-07","current":43.541699,"twenty":-18.815765,"median":-13.180128,"eighty":-8.825258,"marketCap":10242705625},{"date":"2025-03-14","current":40.575946,"twenty":-18.815765,"median":-13.180128,"eighty":-8.721628,"marketCap":9545045021},{"date":"2025-03-21","current":30.296872,"twenty":-18.815765,"median":-13.180128,"eighty":-8.592569,"marketCap":7127005761},{"date":"2025-03-28","current":29.6204,"twenty":-18.815765,"median":-13.180128,"eighty":-8.512782,"marketCap":6967873162},{"date":"2025-04-04","current":24.175625,"twenty":-18.815765,"median":-13.180128,"eighty":-8.405114,"marketCap":5687049798},{"date":"2025-04-11","current":20.752016,"twenty":-18.814976,"median":-13.154716,"eighty":-8.268659,"marketCap":4881683592},{"date":"2025-04-17","current":22.249329,"twenty":-18.814976,"median":-13.154716,"eighty":-8.114977,"marketCap":5233910017},{"date":"2025-04-25","current":25.474946,"twenty":-18.815765,"median":-13.129304,"eighty":-7.839802,"marketCap":5992700828},{"date":"2025-05-02","current":26.222557,"twenty":-18.815765,"median":-13.101968,"eighty":-7.764774,"marketCap":6168568056},{"date":"2025-05-09","current":-14.449479,"twenty":-18.815765,"median":-13.101968,"eighty":-7.70856,"marketCap":3589077208},{"date":"2025-05-16","current":-13.954905,"twenty":-18.815765,"median":-13.101968,"eighty":-7.70856,"marketCap":3466230918},{"date":"2025-05-23","current":-15.347626,"twenty":-18.815765,"median":-13.101968,"eighty":-7.70856,"marketCap":3812166071},{"date":"2025-05-30","current":-15.276407,"twenty":-18.815765,"median":-13.101968,"eighty":-7.70856,"marketCap":3794476205},{"date":"2025-06-06","current":-15.513803,"twenty":-18.815765,"median":-13.101968,"eighty":-7.70856,"marketCap":3853442424},{"date":"2025-06-13","current":-14.76205,"twenty":-18.786702,"median":-13.101968,"eighty":-7.70856,"marketCap":3666716063},{"date":"2025-06-20","current":-8.217844,"twenty":-18.714796,"median":-13.033893,"eighty":-7.695186,"marketCap":2041213954},{"date":"2025-06-27","current":-6.81721,"twenty":-18.637179,"median":-12.845744,"eighty":-7.550572,"marketCap":1693313261},{"date":"2025-07-03","current":-7.216826,"twenty":-18.58593,"median":-12.755864,"eighty":-7.468209,"marketCap":1792573063}],"updateTime":1751888896401}}}